IL-17 can also inhibit adipogenesis and impair obesity development in animal models and thus may be produced in response to increased adiposity or obesity in this patient subset.[42, 43]. The gene discussed is IL17A; the disease is obesity due to melanocortin 4 receptor deficiency.